#68 – IDWeek 2022 Recap: Late Breaking Trials and Pipeline Antibacterials
Breakpoints
00:00
Is This an Uncomplicated UTI Agent?
Eagle one is in gonorrhea. They're looking at female patients age 12 and older with clinic clinically suspected uncomplicated UTIs. And they're randomizing them to either Jepo 1500 twice a day for five days by mouth or an extra few and tone 100 milligrams by mouth twice a dayfor five days. Their primary efficacy composite will be therapeutic response at test of cure around days 10 to 13, then their secondary outcomes will be safety and other things that as you would expect.
Transcript
Play full episode
